Comcapsy 400mg/20mg Tablet contains a combination of Capecitabine 400mg and Cyclophosphamide 20mg in tablet form. It belongs to the ANTI NEOPLASTICS category and is manufactured and marketed by Intas Pharmaceuticals Ltd.
Composition
- Capecitabine: 400mg
- Cyclophosphamide: 20mg
Product Information
- Product Name: Comcapsy 400mg/20mg Tablet
- Generic: Capecitabine 400mg + Cyclophosphamide 20mg
- Dosage Form: Tablet
- Manufacturer: Intas Pharmaceuticals Ltd
- Marketer: Intas Pharmaceuticals Ltd
- Category: ANTI NEOPLASTICS
About Capecitabine and Cyclophosphamide
Capecitabine is an antineoplastic medicine that is converted in the body into 5-fluorouracil (5-FU). It interferes with processes required for cancer cell growth and multiplication.
Cyclophosphamide is an alkylating antineoplastic medicine. It works by damaging the genetic material of rapidly dividing cells, thereby interfering with their growth and multiplication.
This combination may be prescribed as part of a cancer treatment regimen depending on the type of cancer, treatment protocol, and individual patient factors.
Usage Information
Use Comcapsy 400mg/20mg Tablet only under the supervision of an oncologist or qualified healthcare professional. Take it exactly according to the prescribed dose, schedule, and treatment cycle. Do not change the dose or stop treatment without medical advice.
Anticancer treatment with these medicines can cause significant adverse effects and may require regular blood tests and clinical monitoring. Contact your healthcare professional promptly if you develop severe diarrhea, persistent vomiting, mouth sores, unusual bleeding or bruising, fever, signs of infection, or other severe symptoms.
For complete product information, including dosage, administration instructions, treatment schedule, storage conditions, precautions, contraindications, monitoring requirements, and expiry details, refer to the original packaging before use.
